NCT04161664View on ClinicalTrials.gov

Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 16, 2020

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2029

Conditions
Metastatic Squamous Cell Carcinoma of the Vulva
Interventions
DRUG

Paclitaxel and Carboplatin

6 courses of Paclitaxel 175 mg/m2 and Carboplatin AUC 5 in a 3 weekly schedule

Trial Locations (1)

1066CX

RECRUITING

NKI-AVL, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER